G2069 Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
Short descriptor: Med assist tx inject
Look up G2069 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
G2069 is the HCPCS Level II code for Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Priced by carriers (physician fee schedule).
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Priced by carriers (physician fee schedule) (indicator 13)
- Type of Service
- Medical care
- Effective Date
- 2025-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference G2069 with the canonical source and edition:
G2069 — Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program). ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G2069
Canonical URL: https://icd10codingpro.com/hcpcs-codes/G2069